Introduction. Every patient with type 2 diabetes mellitus secretes less insulin than necessary for his/her level of insulin sensitivity, and many of them have some degree of insulin resistance. The mix of insulin defi ciency and insulin resistance is different for each patient and, in any patient, it may vary during the course of the disease. The aim of our study was to examine the degree of -cells function and the presence of insulin resistance in patients with a long-standing type 2 diabetes. Methods. The study included 30 patients of both sexes (12 males, 18 females), with the mean values of age 59 years (SD=7.88) and the disease duration of 10 years (SD=5.36). The mean value of BMI was 31 kg/m² (SD=4.74). The fasting glucose and insulin concentrations and HbA1c in the blood were determined by the standard laboratory methods. The percentages of functional -cells in the pancreas (HOMA-%B), insulin sensitivity (HOMA-%S) and insulin resistance (HOMA-IR) were calculated using a HOMA calculator v2.2. Then, the data were analyzed by statistical software SPSS 19. Results. The mean HbA1c was 10 % (SD=1.52) and FBG 12 mmol/L (SD=4.15). The mean insulin was 13 μmol/L (SD=6.11) and HOMA-%B 31 % (SD=18.99). The median value of HOMA-%S was 49% (32.2-82.4) and HOMA-IR 2 (1.2-3.1). 87% of patients had a HOMA-IR >1. Conclusion. The highly reduced -cells function and the consequent insulin defi ciency, usually combined with the moderate insulin resistance was determined in the patients with a long-standing type 2 diabetes mellitus.
Type 2 diabetes mellitus (T2DM) is the most common form of diabetes and defects of both insulin action and insulin secretion are usually present by the time of diagnosis. It is progressive disorder of glucose metabolism with decreased β-cells function and insulin resistance as the dominant factors in its genesis.¹ The environmental factors, weight gain and physical inactivity exacerbate metabolic abnormalities present in this disease.² Every patient with T2DM secretes less insulin than necessary for his/her level of in-sulin sensitivity, and many of them have some degree of insulin resistance. The mix of insulin defi ciency and insulin resistance is different for each patient and, in any patient, it may vary during the course of the disease.³ Multiple causative factors such as genetic predisposition, insulin resistance, increased insulin secretory demand, glucotoxicity, lipotoxicity, impaired incretin release/action, amylin accumulation and decreased β-cell mass are implicated in pancreatic b-cells impairment.² Insulin resistance, in pharmacological terms, can be defi ned as a state in which the normal amounts of insulin produce a subnormal biological response.⁴ It connotes resistance to the effects of insulin on glucose uptake, me-tabolism or storage. Insulin resistance is manifested by the decreased insulin-stimulated glucose uptake in adipocytes and skeletal muscles and impaired suppression of hepatic glucose output. 5 The main causes of the insulin resistance are genetic predisposition, obesity and physical inactivity. 6 The large amount of abdominal (visceral) fat, found in obese people, is a source of bioactive mediators that directly contribute to insulin resistance and also affect lipid profi les, blood pressure and vascular infl ammation. [7] [8] [9] The fact that T2DM patients have different combinations of β-cells impairment and insulin resistance is well-known, but we have investigated the characteristics of these disorders in a long-standing, poorly controlled T2DM patients treated only by peroral antidiabetics before hospitalization in the Cantonal Hospital Zenica because of the insulin therapy introduction. The assessment of β-cells function and insulin resistance in a long-standing T2DM patients, as well as the assessment of HbA1c and obesity allows setting of an appropriate glycemic target for T2DM patients.
The aim of our study was to examine the degree of β-cells function and the presence of insulin resistance in patients with a long-standing type 2 diabetes.
Materials And Methods
Study subjects. The retrospective study was carried out at the Cantonal Hospital Zenica. The data from medical records of 30 patients of both sexes (12 males, 18 females) with the mean age of 59 years (SD=7.88) were analyzed. The study included the patients with a long-standing T2DM (disease duration more than 5 years) with the mean duration of the disease of 10 years (SD=5.36), treated with peroral antidiabetics. The patients were hospitalized from August 2010 to October 2011 because of the insulin therapy introduction. The body mass index (BMI), an estimate of overall adiposity, was calculated as the weight in kilograms divided by the height in meters squared. The mean value of BMI was 31 kg/m² (SD=4.74).
Laboratory data.
After an overnight fast, the blood samples were drawn for the measurement of fasting blood glucose (FBG), insulin and glycated hemoglobin (HbA1c) concentrations. The measurements were performed at the Department of Laboratory Diagnostics, Cantonal Hospital Zenica by the standard laboratory methods. Specifi cally, glucose concentrations were measured by enzymatic colorimetric assay on Hitachi 912 (Roche, Basel, Switzerland), insulin by chemiluminescentmicroparticle immunoassay on Architect (Abbot, North Chicago, IL, USA) and HbA1c by turbidimetric immunoassay for glycated hemoglobin/ modifi cation of the alkaline hematin reaction for total hemoglobin on Dimension (Siemens, Munich, Germany). The percentages of functional β-cells in pancreas (HOMA-%B), insulin sensitivity (HOMA-%S) and insulin resistance (HOMA-IR) were calculated using a Homeostatic Model Assessment (HOMA) calculator v2.2. Original HOMA 1 model (fi rst described in 1985. by Matthews et al.) is a structural mathematical model which allows values for insulin sensitivity (which is reciprocal of insulin resistance) and β-cells function, expressed as a percentage of normal, to be obtained if fasting plasma glucose and insulin concentrations are known.¹º HOMA 2, currently solved computer model, accounts the differences between hepatic and peripheral insulin secretion or decreases in hepatic glucose production for plasma glucose concentratins above 10 mmol/L, or renal glucose losses. The updated version (1996) of HOMA model incorporates an estimate of proinsulin secretion into the model and allows the use of total or specifi c insulin assays.¹¹ Statistical analysis. The obtained data were analyzed by statistical software SPSS 19(SPSS Inc, Chicago, IL, USA). The results of descriptive statistics were expressed as the mean and standard deviation (SD) or median with the range (25-75 percentile) depending on the data distribution.
Results
The results of descriptive statistics are presented in tables 1. and 2. The mean FBG value was out of the reference range (3.3-6.1 mmol/L). The mean HbA1c value was also out of the reference range (4.8-6.0 %), as expected. The mean blood insulin value was within the reference range (3-17 mmol/L). The mean value of HOMA-%B was highly reduced. The median value of HOMA-%S was reduced and according to that the median value of HOMA-IR was increased moderately.
Statistical parameters
HOMA-IR values were elevated (HOMA-IR>1) in majority of the patients (26 patients, 87%). Variety of combinations of insulin defi ciency and insulin resistance were present.
Discussion
We examined the presence and the degree of β-cells disfunction and insulin resistance in the long-standing T2DM patients. The obtained results revealed the normal insulin level in relative terms. But, in absolute terms, such a level was insuffi cient to maintain normoglycemia in T2DM patients.
Insulin secretion and action govern glucose homeostasis through two feedback loops. A rise in glucose level stimulates insulin secretion, which lowers plasma glucose, but as a consequence, the sustained hyperinsulinemia inhibits both insulin secretion and action.³Finally, persistent plasma glucose elevation (glukotoxicity) impairs β-cells function and leads to hepatic and muscle insulin resistance.¹²All the patients included in the study had a highly reduced β-cells function. We also found that majority of the patients had the moderate insulin resistance.
Our results also show that the patients were poorly controlled and obese. It has been found that obesity accompanies 80 % of the diabetics in the Western world.¹³It is even featured in some subclassifi cations of diabetes but is not required for diabetes diagnosis.³
The weakness of our study is the lack of possibility for comparison of the obtained data with the data at the time of setting the T2DM diagnosis. In spite of that, the published data about initial disfunction show that the progressive decline of β-cells function exists in a longstanding T2DM patients. It has been found that 50-75% of the secretory capacity of the β-cells is already lost by the time fasting hyperglycemia develops.¹⁴Once overt T2DM is present, β-cells function declines progressively with time.²According to United Kingdom Prospective Diabetes Study (UKPDS), the average annual loss of β-cells function in untreated patients is 4%.¹⁵
We have found a variety of combinations of insulin deficiency and insulin resistance in the T2DM patients included in our study. Therefore, estimation of β-cells function and insulin resistance is important for making the medical decision that will lead to the adequate pharmacological interventions (correction of oral therapy, introduction of basal, combined or intensive insulin therapy ) combined with diet and exercise. This approach may improve and preserve β-cells function before it reaches critically low levels.
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